How to Commercialise Research in Biotechnology? PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download How to Commercialise Research in Biotechnology? PDF full book. Access full book title How to Commercialise Research in Biotechnology? by Oliver Uecke. Download full books in PDF and EPUB format.
Author: Oliver Uecke
Publisher: Springer Science & Business Media
ISBN: 3834941344
Category : Business & Economics
Languages : en
Pages : 336
Get Book
Book Description
Biotechnology is considered as a key technology of the 21st century with the potential to offer technological solutions for global health and resource-based problems. Oliver Uecke analyses how early stages of the innovation process in biotechnology can be effectively managed, with the aim to transfer an innovation from academia to industry. A mixed method approach is applied with a multiple case study approach to identify characteristics for effective management and with the method of discrete choice experiments/best-worst scaling to estimate the importance of these characteristics. This study adds to existing research by identifying a group of five important characteristics that should be considered in the early stages of the innovation process, compared to a group of four characteristics that are less important. The results have implications for policy, directors and the management of research institutes and universities, entrepreneurs, TTO manager and other stakeholders involved in technology transfer.
Author: Oliver Uecke
Publisher: Springer Science & Business Media
ISBN: 3834941344
Category : Business & Economics
Languages : en
Pages : 336
Get Book
Book Description
Biotechnology is considered as a key technology of the 21st century with the potential to offer technological solutions for global health and resource-based problems. Oliver Uecke analyses how early stages of the innovation process in biotechnology can be effectively managed, with the aim to transfer an innovation from academia to industry. A mixed method approach is applied with a multiple case study approach to identify characteristics for effective management and with the method of discrete choice experiments/best-worst scaling to estimate the importance of these characteristics. This study adds to existing research by identifying a group of five important characteristics that should be considered in the early stages of the innovation process, compared to a group of four characteristics that are less important. The results have implications for policy, directors and the management of research institutes and universities, entrepreneurs, TTO manager and other stakeholders involved in technology transfer.
Author:
Publisher:
ISBN:
Category : Biotechnology industries
Languages : en
Pages : 28
Get Book
Book Description
Author: Arpita Saxena
Publisher: Springer Nature
ISBN: 3030361306
Category : Technology & Engineering
Languages : en
Pages : 197
Get Book
Book Description
This book is an effort to foster the entrepreneurial spirit in young minds. It reviews a wide range of product ideas, opportunities and challenges associated with start-ups. In addition, it discusses popular molecular targets for biotechnology research / the biotech industry such as attenuated microbes, gene sequences, biomarkers, and the latest advance in the sector, CRISPR. These molecular targets can be modified for the production of sufficient quantities of food and fuel. Very often, researchers limit their focus to the proof of concept, and fail to successfully convert it into a finished product. To help young entrepreneurs avoid this pitfall, the book addresses various aspects like intellectual property regulations, commerce and management. The book’s contributing authors hail from various specialized sectors, and from around the globe. Taken together, the respective chapters are intended to overcome the borders between disciplines that otherwise rarely interact.
Author: Craig D. Shimasaki
Publisher: Springer Science & Business Media
ISBN: 1441900640
Category : Medical
Languages : en
Pages : 282
Get Book
Book Description
My journey into this fascinating field of biotechnology started about 26 years ago at a small biotechnology company in South San Francisco called Genentech. I was very fortunate to work for the company that begat the biotech industry during its formative years. This experience established a solid foundation from which I could grow in both the science and business of biotechnology. After my fourth year of working on Oyster Point Boulevard, a close friend and colleague left Genentech to join a start-up biotechnology company. Later, he approached me to leave and join him in of all places – Oklahoma. He persisted for at least a year before I seriously considered his proposal. After listening to their plans, the opportunity suddenly became more and more intriguing. Finally, I took the plunge and joined this ent- preneurial team in cofounding and growing a start-up biotechnology company. Making that fateful decision to leave the security of a larger company was extremely difficult, but it turned out to be the beginning of an entrepreneurial career that forever changed how I viewed the biotechnology industry. Since that time, I have been fortunate to have cofounded two other biotechnology com- nies and even participated in taking one of them public. During my career in these start-ups, I held a variety of positions, from directing the science, operations, regulatory, and marketing components, to subsequently becoming CEO.
Author: Craig Shimasaki
Publisher: Academic Press
ISBN: 0124047475
Category : Medical
Languages : en
Pages : 488
Get Book
Book Description
As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a ‘how-to’ for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars Case studies are interspersed throughout each chapter to support key concepts and best practices. Enhanced by use of numerous detailed graphics, tables and flow charts
Author: Oliver Uecke
Publisher: World Scientific
ISBN: 1783266821
Category : Technology & Engineering
Languages : en
Pages : 292
Get Book
Book Description
Biotechnology is referred to as one of the key enabling technologies of the 21st century. It has the potential to offer solutions for a number of health and resource-based problems the world is facing, such as unmet medical needs and fossil fuel dependency. Considerable effort and investment has been expended in recent years to try and improve the outcomes of technology transfer in order to fulfill this potential. This book presents seventeen best-practice case studies on the topic of effective technology transfer in biotechnology. The selected case studies focus on technology transfer offices, funding models, incubators, education and clusters. Each presents an overview of an initiative that was deployed in Europe with the aim of supporting and stimulating the transfer of biotechnology discoveries and technologies from research laboratories to society. Readers are provided with a critical assessment of each initiative and policy makers, entrepreneurs, cluster managers and research institute managers will find inspiring lessons they can draw on when developing and implementing similar initiatives elsewhere. These cases are the product of research undertaken as part of the ETTBio (Effective Technology Transfer in Biotechnology) project, co-financed by the European Union (ERDF — European Regional Development Fund) and made possible by the INTERREG IVC Programme. ETTBio commenced in January 2012 and concluded in December 2014. Contents:Technology Transfer Office (TTO):Case Study 1: A Look Inside Imperial College's TTOCase Study 2: Technology Transfer at VIBCase Study 3: The Creation of a New Technology Transfer OfficeCase Study 4: A Model for IP Transfer and Shareholding for University Spin-Offs: The "Dresden Model"Funding:Case Study 5: Environmental Success Factors of Imperial College's TTOCase Study 6: The Industrial Research FundCase Study 7: Regional Innovation Vouchers as an Effective Tool for Supporting Technology TransferCase Study 8: Public Funds for Patenting, Valorization and Science-Industry CollaborationIncubators:Case Study 9: The Imperial BioincubatorCase Study 10: Idea Lab — A Platform for Students to Develop New IdeasEducation:Case Study 11: Entrepreneurship and Technology Transfer Education at the Vrije Universiteit BrusselCase Study 12: BioEmprenedor XXI: Guidance Program for Starting Up and Growing Companies in the Life Sciences ArenaCase Study 13: Education for ScientistsClusters:Case Study 14: The Biocat Model: Managing the Bioregion of CataloniaCase Study 15: The Effects of a Cluster on a Spin-Off — The Foundation of AblynxCase Study 16: Brokerage Event: Matching International R&D projectsCase Study 17: The DRESDEN-concept: A Focus on Shared Services and Facilities Readership: Policy makers, entrepreneurs, cluster managers and research institute managers in biotechnology. Key Features:Focuses on effective technology transfer in the European contextTechnology specific focus on biotechnologyIdentifies and provides a detailed examination of best practice case studies in technology transfer across Europe. These include both highly experienced regions such as London and Flanders as well as "newcomers" such as Poland and EstoniaKeywords:Technology Transfer;Biotechnology;Effectiveness;Efficiency;Commercialization;Research;Funding;Cluster;Education;Technology Transfer Offices;Incubation
Author: Neil F. Sullivan
Publisher: Cambridge University Press
ISBN: 9780521466165
Category : Science
Languages : en
Pages : 240
Get Book
Book Description
The purpose of this book is to help research scientists exploit their ideas commercially.
Author: Donald L. Drakeman
Publisher: Oxford University Press
ISBN: 0195084004
Category : Biotechnology industries
Languages : en
Pages : 241
Get Book
Book Description
"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--
Author: Alberto Onetti
Publisher: Routledge
ISBN: 1317919130
Category : Business & Economics
Languages : en
Pages : 212
Get Book
Book Description
Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.
Author: Gary P. Pisano
Publisher: Harvard Business Press
ISBN: 9781591398400
Category : Business & Economics
Languages : en
Pages : 278
Get Book
Book Description
Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.
